Keyword: Health, diagnostics and drug development

This page displays contents related to the keyword.

BioCity Student Symposium – Students are the Solution, 24 August 2022

13.05.2022

This year BioCity Student Symposium titled Students are the Solution is arranged on-site by PhD researchers from The University of Turku and Abo Akademi University together with BioCity Turku and InFLAMES Flagship in Cave theatre - Visitor and Innovation Centre Joki, 24th August 2022.

31st BioCity Symposium 25-26 August 2022

01.04.2022

This year BioCity Symposium is arranged on-site in Mauno Conference Centre, BioCity, together with InFLAMES Research Flagship 25–26 August 2022, with the title Solution is in Immunity. Registration is now open until 11 August 2022.

Call for BioCity Turku new research programs – Deadline 15 April

21.03.2022

BioCity Turku is an umbrella organization supporting and coordinating research on life sciences and molecular medicine in University of Turku and Åbo Akademi University. BioCity Turku research programs strengthen the multidisciplinary and interdisciplinary research collaboration within the Turku campus. BioCity Turku asks for proposals for new research programs for 2022-2026.

Frontiers of Science Seminar Program for Autumn 2021 is Ready

31.08.2021

BioCity Turku arranges every semester Frontiers of Science seminar series where researchers are welcome to invite prominent international scientists to give a talk to local scientific community. The seminars are for all researchers and students and students can get ECTs from participation.

BioCity Symposium Celebrates its 30th Anniversary in August 2021

11.05.2021

The annual BioCity Symposium is in August 19th–20th with the title Cancer – Breaking Bad. This series of meetings organized since 1991 has become the most important annual get-together in the fields of biosciences and molecular medicine in Turku. The symposium gathers together hundreds of participants each year and offers talks from cutting-edge international researchers.

Adverse Cardiovascular Risk Factor Profile from Childhood to Midlife Associates with Poor Cognitive Performance

10.05.2021

A Finnish study coordinated by the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku shows that exposure to cardiovascular risk factors, such as high blood pressure, elevated serum cholesterol, and obesity, from childhood to midlife are associated with poor cognitive performance in midlife. Importantly, the worse the cardiovascular risk factor profile and the higher the number of the risk factors was, the poorer cognitive performance was observed.